Keyphrases
Leukemia Cell Lines
100%
Antitumor Effect
100%
K562
100%
Non-steroidal
100%
Glucocorticoid Receptor Ligands
100%
CpdA
100%
Glucocorticoid Receptor
50%
Bortezomib
30%
Triamcinolone Acetonide
30%
Transrepression
20%
Receptor Transactivation
20%
Hematological Malignancies
10%
Chemotherapy
10%
Chloride
10%
Transcription Factor
10%
Protease Inhibitors
10%
Leukemia
10%
Cell Viability
10%
NF-B
10%
Cell Growth
10%
Leukemia Therapy
10%
Receptor Targets
10%
Therapeutic Impact
10%
Metabolic Complications
10%
Luciferase Assay
10%
T-cell Leukemia
10%
Cytotoxic Activity
10%
Apoptotic Effect
10%
Chloro
10%
Caspase-dependent Apoptosis
10%
Potentiating Effect
10%
Cytostatic Effect
10%
Selective Glucocorticoid Receptor Modulators
10%
FKBP51
10%
CEM Cells
10%
AP-1 Factors
10%
Glucocorticoid Receptor Dimerization
10%
K562 Leukemia Cells
10%
Pharmacology, Toxicology and Pharmaceutical Science
Leukemia
100%
Glucocorticoid Receptor
100%
Glucocorticoid
55%
Bortezomib
33%
Fluocinolone Acetonide
33%
Side Effect
22%
Receptor Agonist
11%
Chemotherapy
11%
Chemotherapy of Hematological Malignancy
11%
T Cell Leukemia
11%
Transcription Factors
11%
Proteasome Inhibitor
11%
Luciferase
11%
Caspase
11%
Cytotoxicity
11%
Cytostatic
11%